| Identification | |
| Name: | 18,19-Dinorpregn-4-en-20-yn-3-one,17-(acetyloxy)-13-ethyl-, 3-oxime, (17a)- |
| Synonyms: | D138;Dexnorgestrel acetime;Norgestimate;ORF 10131;RWJ 10131;d-(17a)-17-Acetoxy-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-oneoxime; |
| CAS: | 35189-28-7 |
| Molecular Formula: | C23H31NO3 |
| Molecular Weight: | 369.5 |
| InChI: | InChI=1/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 254.9°C |
| Boiling Point: | 497.9°Cat760mmHg |
| Density: | 1.22g/cm3 |
| Refractive index: | 1.611 |
| Appearance: | white crystalline solid |
| Specification: |
18,19-Dinorpregn-4-en-20-yn-3-one,17-(acetyloxy)-13-ethyl-, 3-oxime, (17a)- , with CAS number of 35189-28-7, can be called (+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one Oxime Acetate (Ester) ; (3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate ; (3E,8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate (non-preferred name) ; (3E,8R,9S,10R,13S,14S,17R)-17-Ethinyl-13-ethyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylacetat ; acétate de (3E,8R,9S,10R,13S,14S,17R)-13-éthyl-17-éthynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yle . It is a white crystalline solid, 18,19-Dinorpregn-4-en-20-yn-3-one,17-(acetyloxy)-13-ethyl-, 3-oxime, (17a)- (CAS NO.35189-28-7) can be used as a progestogen. In combination with estrogen as oral contraceptive. |
| Flash Point: | 254.9°C |
| Usage: | Progestogen. In combination with estrogen as oral contraceptive |
| Safety Data | |
 |
|
